Abstract
Thirty-three patients have undergone BCG intralesional injection into pulmonary tumors. Six received the injection by way of the bronchoscope and 27 were injected percutaneously under fluoroscopic control. The toxicity of this treatment is closely related to PPD reactivity. PPD-negative patients have little fever and malaise. However patients with strongly positive PPD reactions have extensive and prolonged fever. Twenty-six of the 27 patients injected with BCG underwent pulmonary resection. There were no significant postoperative complications. Histologically BCG induces a granulomatous inflammatory reaction, and in the patients who are PPD-positive there is extensive plasma-cell infiltration andde novo germinal center formation within the tumor. Eighty-five percent of the patients with bronchogenic carcinoma and 58 percent of the paitents with metastatic cancer are alive and well at a median follow-up of 16 months following pulmonary resection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amery, W. K.: A placebo-controlled levamisole study in resectable lung cancer, In W. D. Terry and D. Windhorst (eds.), Immunotherapy of Cancer: Present Status of Trials in Man, pp. 191–201, Raven Press, New York, 1978.
Azuma, I., Taniyama, T., Hirao, F. and Yamamura, Y.: Antitumor activity of cell-well skeleton of Mycobacteria and related organisms in mice and rabbits,Gann 65: 493–505, 1974.
Giuliano, A. E., Rangel, D. M., Golub, S. H., Holmes, E. C. and Morton, D. L.: Immunosuppression in lung cancer,Cancer (in press).
Hanna, M. G. Jr.: Immunological aspects of BCG-mediated aggression of established tumors and metastases in guinea pigs.Semin. Oncol. 1: 319–335, 1974.
Hanna, M. G. Jr., Peters, L. C. and Fidler, I. J.: The efficacy of BCG-induced tumor immunity in guinea pigs with regional and systemic malignancy,Cancer Immunol. Immunother. 1: 171–177, 1976.
Herberman, R. B., Perlin, E., Reid, J., Miller, C., Bonnard, G. D., Weese, J. L., Glom, J. and Connor, R. J.: Immunotherapy of lung cancer with BCG and allogeneic tumor cells. Proc. World Conf. Lung Cancer, p. 28, 1978.
Holmes, E. C. and Golub, S. H.: Immunologic defects in lung cancer patients,J. Thorac. Cardiovasc. Surg. 71: 161–168, 1976.
Holmes, E. C. and Golub, S. H.: Effect of levamisole on cell-mediated immunity in patients with lung cancer, In M. A. Chirigos (ed.), Immune Modulation and Control of Neoplasia by Adjuvant Therapy, pp. 107–118, Raven Press, New York, 1978.
McKneally, M. F., Maver, C., Kausel, H. W. and Alley, R. D.: Regional immunotherapy with intrapleural BCG for lung cancer: Surgical considerations,J. Thorac. Cardiovasc. Surg. 72: 333–338, 1976.
Morton, D. L., Eilber, F. R., Holmes, E. C., Hunt, J. S., Ketcham, A. S., Silverstein, M. J. and Sparks, F. C.: BCG immunotherapy of malignant melanoma,Ann. Surg. 180: 635–643, 1974.
Nathanson, L.: Use of BCG in the treatment of human neoplasms: A review,Semin. Oncol. 1: 337–350, 1974.
Yasumoto, K., Manabe, H., Ueno, M., Ohta, M., Hidehiko, U., Akira, I., Nomoto, K., Azuma, I. and Yamamura, Y.: Immunotherapy of human lung cancer with BCG cell-wall skeleton,Gann 67: 787–795, 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holmes, E.C. BCG immunotherapy of lung cancer. The Japanese Journal of Surgery 10, 1–6 (1980). https://doi.org/10.1007/BF02468640
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02468640